TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Although the association of TM6SF2 rs58542926 and the spectrum of NAFLD disease is controversial, several studies have demonstrated that the loss-of-function variant rs58542926 could be considered a risk factor in NAFLD and fibrosis progression [46].